Gutwerg Ori 4

What Happened

• Ori Gutwerg, Senior Vice President, Generics at ANI Pharmaceuticals (ANIP), had 4,267 shares withheld by the company on 2026-02-11 to satisfy tax withholding obligations. The shares are recorded at $76.25 each, for a total value of $325,359. This is coded as a tax-withholding disposition (Code F), not an open-market sale.

Key Details

• Transaction date: 2026-02-11
• Price per share: $76.25; shares withheld: 4,267; value: $325,359
• Transaction type: Tax withholding on vesting of equity (Code F — shares withheld to cover tax liability)
• Related award: Withholding was in connection with vesting of 11,578 performance stock units (grant previously reported April 6, 2023); withholding is exempt under Rule 16b-3 (per filing footnote)
• Shares owned after transaction: Not specified in the provided filing
• Filing date: 2026-02-13 — filed within the typical 2-business-day Form 4 window (timely)

Context

• This was a routine tax-withholding event tied to the vesting of performance stock units. The company retained (withheld) shares to cover the insider’s tax liability rather than the insider selling shares on the open market; such transactions are standard for equity compensation and do not necessarily indicate the insider’s view on the stock.